Status:
COMPLETED
The Tobramycin Study
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
The National Institute of Health, Oslo
Ullevaal University Hospital
Conditions:
Neutropenia
Fever
Eligibility:
All Genders
16-70 years
Phase:
PHASE4
Brief Summary
Evaluate if tobramycin given once a day is at least as efficacious as the traditional tobramycin given three times a day, given with penicillin G, til patients with febrile neutropenia.
Detailed Description
Prospective randomized Norwegian multicenter clinical trial (11 hospitals) comparing tobramycin given once a day (new regimen) vs. three times a day (current regimen), with penicillin G, to cancer pat...
Eligibility Criteria
Inclusion
- Febrile neutropenia Cancer Adult (16-70) Signed informed consent
Exclusion
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00257790
Start Date
September 1 2001
End Date
March 1 2005
Last Update
July 6 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.